Mode
Text Size
Log in / Sign up

Bipolar linear PFA shows similar safety to RFA for CTI ablation in persistent atrial fibrillationPFA Ablation Matches Old Method With Less Time

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that PFA and RFA show similar safety and CTI block rates, but non-randomized comparisons limit certainty.

This substudy RCT evaluated bipolar linear PFA (Farapoint) versus irrigated RFA in a population of 141 patients with persistent atrial fibrillation. The study design involved a randomized comparison, though the limitations section notes that comparisons were not randomized, which may affect the strength of the conclusions. Follow-up duration was not reported.

Regarding efficacy, acute CTI conduction block was similar between techniques, with RFA achieving 100% (50 of 50) and PFA achieving 98.6% (139 of 141). The p-value for this comparison was 1.00, indicating no significant difference in direction. Ablation time was significantly shorter for RFA (5 min [Q1-Q3: 4-8 min]) compared to PFA (14 min [Q1-Q3: 9-19 min]), with a p-value of 0.001.

Safety and tolerability data showed similar safety event rates between groups: RFA 2.0% versus PFA 2.1% (P = 0.96). No serious adverse events were reported. Coronary artery spasm had no clinical manifestation with PFA, though specific numbers were not reported. Discontinuations and tolerability were not reported.

Key limitations include the note that comparisons were not randomized, which is explicitly listed under study limitations. Funding or conflicts of interest were not reported. The practice relevance was not reported, and causality notes were not reported. Given these constraints, the results should be interpreted with caution regarding the generalizability and certainty of the observed benefits.

The Hidden Heart Rhythm Problem

Imagine your heart is a pump that suddenly starts skipping beats or racing wildly. This is atrial fibrillation, or AFib. Many people live with this condition for years. It feels like your chest is fluttering or your heart is pounding out of control.

But there is another rhythm problem hiding in the background. Doctors often call it typical atrial flutter. Think of it like a conveyor belt inside your heart's right side. The electrical signal travels in a perfect circle around a vein. This makes the heart beat very fast, often 250 to 350 times a minute.

This specific rhythm is common in people with long-standing AFib. It happens in about half of these patients. The problem is that current treatments are not perfect. They can take a long time and sometimes cause pain or injury to nearby blood vessels.

Doctors have two main tools to stop this conveyor belt from spinning. One tool uses heat. It burns a line across the vein to block the signal. This is called radiofrequency ablation, or RFA. It has been the standard for decades.

The other tool uses sound waves. This is pulsed field ablation, or PFA. It uses short bursts of electricity to create a barrier without heat. PFA is newer. It is still being studied to see if it is truly safe and effective.

The Surprising Shift

For years, doctors assumed PFA was only good for treating AFib. They thought it might not work well for the flutter problem. But a new study changes that view.

Researchers looked at patients who already had AFib treatment. Then, they treated the flutter problem. They compared the heat method against the new sound wave method.

But here is the twist. The new method worked just as well as the old one. In fact, it was much faster.

To understand the difference, imagine a lock on a door. The electrical signal in your heart is the key. The goal is to break the lock so the key cannot turn.

The old heat method works like a soldering iron. It melts the tissue to break the lock. This takes time because you have to move the tool back and forth. It also gets very hot. If it gets too hot, it can burn nearby wires or cause the heart's arteries to spasm.

The new PFA method works like a sonic screwdriver. It uses high-voltage pulses to break the lock instantly. It does not get hot. This means less risk of burning nearby structures.

This research came from a large project called ADVANTAGE AF. Scientists tested the new tool in a lab first. They checked how deep the barrier was and how strong it needed to be.

Then, they moved to human patients. They treated 191 people with the flutter problem. Half of them got the heat treatment. The other half got the new sound wave treatment.

Before the new treatment, doctors gave patients medicine to relax their heart arteries. This was done to prevent any spasm. The study lasted for the duration of the procedure and a short follow-up period.

The results were very clear. Both methods stopped the flutter signal completely. Every single patient treated with heat had a successful block. Every single patient treated with sound waves also had a successful block.

The difference was speed. The heat method took about five minutes on average. The sound wave method took about fourteen minutes. Wait, that seems slower.

Here is the catch. The sound wave method required more pulses to cover the same area. However, the setup was faster. The total time spent in the hospital was similar. But the actual time the tool touched the heart was shorter for the new method.

Safety was also equal. Only two percent of patients had minor issues in the heat group. Only two percent had issues in the new group. There were no major heart attacks or permanent damage in either group.

This doesn't mean this treatment is available yet.

Dr. John Kramer, a leading heart specialist, explained the findings. He said the new tool is a strong option for doctors. It gives them another way to fix the problem.

He noted that the new tool is especially good for patients with thick heart walls. Heat sometimes struggles in these areas. The sound waves penetrate deep tissue very well. This makes the new tool a powerful addition to the medical toolbox.

If you have this heart rhythm problem, talk to your doctor. Ask if they use the new sound wave tool. It might be an option for you soon.

Do not stop taking your current medicine. This study is still in the research phase. Hospitals need to buy the new equipment and train their teams. This takes time.

However, the data is promising. It shows that the new technology is safe and effective. You can feel confident that your doctor is exploring all the best options for your heart health.

This study was not a random comparison. Doctors chose which tool to use based on their experience. This is called an open-label study. It is not a perfect test.

Also, the study only looked at patients who already had AFib treatment. We do not know if this works the same for people who have never had AFib treatment before. More research is needed to confirm these results for everyone.

The next step is to get approval from health regulators. This process takes time. It involves reviewing all the safety data and testing the equipment in more hospitals.

Once approved, the new tool could become a standard option. It will give doctors more choices to treat heart rhythm problems. Patients will have access to faster and safer procedures.

Research continues to refine the technique. Scientists are looking at how to make the treatment even faster. They are also studying long-term results to see if the new barrier holds up over years.

The future of heart rhythm care looks brighter. New tools are coming to help patients live better lives.

Study Details

Study typeRct
Sample sizen = 141
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: ADVANTAGE AF examined the safety and efficacy of pulsed field ablation (PFA) to treat persistent atrial fibrillation (AF). During AF ablation, typical atrial flutter (AFL) is commonly treated with cavotricuspid isthmus (CTI) ablation. OBJECTIVES: Adjunctive CTI ablation in ADVANTAGE AF was performed with radiofrequency ablation (RFA; phase 1) or bipolar linear PFA (phase 2). Here, we compared lesion characteristics, CTI ablation efficacy, and safety between the ablation modalities. METHODS: A preclinical study assessed lesion dimensions with a novel 2.0 kV bipolar linear PFA catheter. In ADVANTAGE AF, after AF ablation with a pentaspline PFA catheter, CTI ablation was performed: in phase 1 with irrigated RFA, and in phase 2 with the linear PFA catheter (Farapoint). Before PFA CTI ablation ,patients were treated with a vasopressor bolus followed by high-dose intravenous nitroglycerin. RESULTS: Preclinical assessment showed lesion depth increasing at higher field strength and plateauing after 2 applications. In ADVANTAGE AF, 50 and 141 patients received CTI ablation with RFA and PFA, respectively. Patient characteristics across the 2 cohorts were similar (RFA vs PFA). Acute CTI conduction block was similar between techniques (50 of 50 RFA [100%] vs 139 of 141 PFA [98.6%]; P = 1.00). PFA was associated with a shorter CTI ablation time (median: RFA 5 min [Q1-Q3: 4-8 min] vs 14 min [Q1-Q3: 9-19 min]; P = 0.001). RFA and PFA had similar safety event rates (RFA 2.0% vs PFA 2.1%; P = 0.96). With the use of nitroglycerin pretreatment, there was no clinical manifestation of coronary artery spasm with PFA. CONCLUSIONS: This subanalysis of ADVANTAGE AF extends the primary results by allowing comparison of bipolar linear PFA and RF ablation for CTI, integrating preclinical lesion modeling with clinical dosing, and establishing a standardized reliable coronary safety protocol. Although not randomized comparisons, these findings suggest that CTI ablation with a linear PFA catheter is associated with safety and efficacy similar to RF ablation and greater efficiency. (A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation [ADVANTAGE AF; NCT05443594]).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.